Expression of Pregnancy Specific β-1 Glycoprotein 1 in Cervical Cancer Cells

Cervical Cancer (CC) is a worldwide public health concern associated with genetic alterations, among these the gain of the 19q chromosome harboring the Pregnancy Specific Glycoproteins (PSG) gene family. These proteins play a critical role in pregnancy, with participation in immunotolerance, angioge...

Full description

Saved in:
Bibliographic Details
Published inArchives of medical research Vol. 51; no. 6; pp. 504 - 514
Main Authors Rodríguez-Esquivel, Miriam, Romero-Morelos, Pablo, Taniguchi-Ponciano, Keiko, Mendoza-Rodríguez, Mónica, Marrero-Rodríguez, Daniel, Bandera-Delgado, Arfy, Huerta-Padilla, Victor, Serna-Reyna, Luis, Gómez-Gutiérrez, Guillermo, Gómez-Virgilio, Laura, Bandala, Cindy, López-Romero, Ricardo, Garrido-Guerrero, Efraín, Chanona-Pérez, Jorge, Salcedo, Mauricio
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cervical Cancer (CC) is a worldwide public health concern associated with genetic alterations, among these the gain of the 19q chromosome harboring the Pregnancy Specific Glycoproteins (PSG) gene family. These proteins play a critical role in pregnancy, with participation in immunotolerance, angiogenesis, and invasion processes, which are also observed in carcinogenesis. The aim of this study was to determine the molecular alterations of PSG1 and its relationship with CC. PSG1 Copy Number Variation (CNV) was evaluated in 31 CC and eight normal cervical tissues by qPCR. PSG1 expression was correlated with HPV detection and IL-10 and TGF-β expression in CC samples. Finally, PSG1 protein expression was evaluated by immunofluorescence in CC cell lines, by immunohistochemistry in a tissue microarray, and by immunoblotting in the sera of women with normal cervix, pre-invasive lesions, and CC. PSG1 showed a gain of 25.6% in CNV and gene expression in CC. There was a lack of PSG1 expression in normal cervical epithelium and positive immunostaining in 57% of CC tissues, while all CC cell lines expressed PSG1. Finally, PSG1 was immunodetected in 90% of pre-invasive lesions and in all CC serum samples, but not in healthy women. PSG1 expression correlates with the expression of IL-10 and TGF-β in CC tissues, but not with the presence of HPV. These data show evidence of the differential expression of PSG1 in CC that could explain its participation in tumor-biology and immunotolerance mechanisms. Further, its immunodetection could provide early detection of this cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0188-4409
1873-5487
DOI:10.1016/j.arcmed.2020.05.025